vs
MDU RESOURCES GROUP INC（MDU）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是MDU RESOURCES GROUP INC的1.5倍（$772.1M vs $522.6M），MDU RESOURCES GROUP INC净利率更高（14.6% vs 12.7%，领先1.9%），Revvity同比增速更快（5.9% vs -1.6%），Revvity自由现金流更多（$161.8M vs $-336.0M），过去两年Revvity的营收复合增速更高（9.0% vs -5.7%）
MDU资源集团是一家总部位于美国北达科他州俾斯麦的企业，业务涵盖受监管的能源输送供应，以及公用事业相关的建筑材料与服务，业务范围覆盖美国48个州，是当地能源及基建服务领域的重要参与者。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
MDU vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$522.6M
营收增速更快
RVTY
高出7.4%
-1.6%
净利率更高
MDU
高出1.9%
12.7%
自由现金流更多
RVTY
多$497.8M
$-336.0M
两年增速更快
RVTY
近两年复合增速
-5.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $522.6M | $772.1M |
| 净利润 | $76.3M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 20.5% | 14.5% |
| 净利率 | 14.6% | 12.7% |
| 营收同比 | -1.6% | 5.9% |
| 净利润同比 | 38.4% | 3.9% |
| 每股收益（稀释后） | $0.37 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDURVTY
| Q4 25 | $522.6M | $772.1M | ||
| Q3 25 | $313.6M | $698.9M | ||
| Q2 25 | $348.7M | $720.3M | ||
| Q1 25 | $678.0M | $664.8M | ||
| Q4 24 | $531.0M | $729.4M | ||
| Q3 24 | $290.7M | $684.0M | ||
| Q2 24 | $343.1M | $691.7M | ||
| Q1 24 | $588.2M | $649.9M |
净利润MDURVTY
| Q4 25 | $76.3M | $98.4M | ||
| Q3 25 | $18.3M | $46.7M | ||
| Q2 25 | $13.8M | $53.9M | ||
| Q1 25 | $82.0M | $42.2M | ||
| Q4 24 | $55.2M | $94.6M | ||
| Q3 24 | $64.6M | $94.4M | ||
| Q2 24 | $60.4M | $55.4M | ||
| Q1 24 | $100.9M | $26.0M |
毛利率MDURVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率MDURVTY
| Q4 25 | 20.5% | 14.5% | ||
| Q3 25 | 12.7% | 11.7% | ||
| Q2 25 | 8.7% | 12.6% | ||
| Q1 25 | 16.6% | 10.9% | ||
| Q4 24 | 17.8% | 16.3% | ||
| Q3 24 | 12.0% | 14.3% | ||
| Q2 24 | 11.5% | 12.4% | ||
| Q1 24 | 16.4% | 6.8% |
净利率MDURVTY
| Q4 25 | 14.6% | 12.7% | ||
| Q3 25 | 5.8% | 6.7% | ||
| Q2 25 | 4.0% | 7.5% | ||
| Q1 25 | 12.1% | 6.4% | ||
| Q4 24 | 10.4% | 13.0% | ||
| Q3 24 | 22.2% | 13.8% | ||
| Q2 24 | 17.6% | 8.0% | ||
| Q1 24 | 17.2% | 4.0% |
每股收益（稀释后）MDURVTY
| Q4 25 | $0.37 | $0.86 | ||
| Q3 25 | $0.09 | $0.40 | ||
| Q2 25 | $0.07 | $0.46 | ||
| Q1 25 | $0.40 | $0.35 | ||
| Q4 24 | $0.26 | $0.77 | ||
| Q3 24 | $0.32 | $0.77 | ||
| Q2 24 | $0.30 | $0.45 | ||
| Q1 24 | $0.49 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.2M | $919.9M |
| 总债务越低越好 | $2.7B | — |
| 股东权益账面价值 | $2.8B | $7.3B |
| 总资产 | $7.6B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.97× | — |
8季度趋势，按日历期对齐
现金及短期投资MDURVTY
| Q4 25 | $28.2M | $919.9M | ||
| Q3 25 | $75.9M | $931.4M | ||
| Q2 25 | $58.8M | $991.8M | ||
| Q1 25 | $59.5M | $1.1B | ||
| Q4 24 | $66.9M | $1.2B | ||
| Q3 24 | $88.3M | $1.2B | ||
| Q2 24 | $78.8M | $2.0B | ||
| Q1 24 | $72.7M | $1.7B |
总债务MDURVTY
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.3B | — |
股东权益MDURVTY
| Q4 25 | $2.8B | $7.3B | ||
| Q3 25 | $2.7B | $7.4B | ||
| Q2 25 | $2.7B | $7.6B | ||
| Q1 25 | $2.7B | $7.6B | ||
| Q4 24 | $2.7B | $7.7B | ||
| Q3 24 | $3.1B | $7.9B | ||
| Q2 24 | $3.0B | $7.9B | ||
| Q1 24 | $3.0B | $7.8B |
总资产MDURVTY
| Q4 25 | $7.6B | $12.2B | ||
| Q3 25 | $7.2B | $12.1B | ||
| Q2 25 | $6.9B | $12.4B | ||
| Q1 25 | $7.0B | $12.4B | ||
| Q4 24 | $7.0B | $12.4B | ||
| Q3 24 | $8.2B | $12.8B | ||
| Q2 24 | $8.0B | $13.4B | ||
| Q1 24 | $7.8B | $13.4B |
负债/权益比MDURVTY
| Q4 25 | 0.97× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 0.76× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.6M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-336.0M | $161.8M |
| 自由现金流率自由现金流/营收 | -64.3% | 21.0% |
| 资本支出强度资本支出/营收 | 79.7% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.06× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-297.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流MDURVTY
| Q4 25 | $80.6M | $182.0M | ||
| Q3 25 | $57.9M | $138.5M | ||
| Q2 25 | $117.4M | $134.3M | ||
| Q1 25 | $217.5M | $128.2M | ||
| Q4 24 | $60.5M | $174.2M | ||
| Q3 24 | $140.2M | $147.9M | ||
| Q2 24 | $136.5M | $158.6M | ||
| Q1 24 | $165.1M | $147.6M |
自由现金流MDURVTY
| Q4 25 | $-336.0M | $161.8M | ||
| Q3 25 | $-121.9M | $120.0M | ||
| Q2 25 | $36.5M | $115.5M | ||
| Q1 25 | $124.4M | $112.2M | ||
| Q4 24 | $-95.8M | $149.8M | ||
| Q3 24 | $673.0K | $125.6M | ||
| Q2 24 | $26.5M | $136.6M | ||
| Q1 24 | $48.1M | $129.7M |
自由现金流率MDURVTY
| Q4 25 | -64.3% | 21.0% | ||
| Q3 25 | -38.9% | 17.2% | ||
| Q2 25 | 10.5% | 16.0% | ||
| Q1 25 | 18.4% | 16.9% | ||
| Q4 24 | -18.0% | 20.5% | ||
| Q3 24 | 0.2% | 18.4% | ||
| Q2 24 | 7.7% | 19.7% | ||
| Q1 24 | 8.2% | 20.0% |
资本支出强度MDURVTY
| Q4 25 | 79.7% | 2.6% | ||
| Q3 25 | 57.3% | 2.6% | ||
| Q2 25 | 23.2% | 2.6% | ||
| Q1 25 | 13.7% | 2.4% | ||
| Q4 24 | 29.4% | 3.4% | ||
| Q3 24 | 48.0% | 3.3% | ||
| Q2 24 | 32.0% | 3.2% | ||
| Q1 24 | 19.9% | 2.7% |
现金转化率MDURVTY
| Q4 25 | 1.06× | 1.85× | ||
| Q3 25 | 3.16× | 2.97× | ||
| Q2 25 | 8.52× | 2.49× | ||
| Q1 25 | 2.65× | 3.03× | ||
| Q4 24 | 1.10× | 1.84× | ||
| Q3 24 | 2.17× | 1.57× | ||
| Q2 24 | 2.26× | 2.87× | ||
| Q1 24 | 1.64× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDU
| Natural Gas Distribution | $382.8M | 73% |
| Commercial Utility Sales | $42.7M | 8% |
| Residential Utility Sales | $33.7M | 6% |
| Pipelineand Midstream | $31.1M | 6% |
| Natural Gas Transportation | $17.2M | 3% |
| Industrial Utility Sales | $10.1M | 2% |
| Natural Gas Storage | $6.4M | 1% |
| Other Utility Sales | $1.9M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
